ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

DMK DMK Pharmaceuticals Corporation

0,232
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
DMK Pharmaceuticals Corporation DMK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,232 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,232
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
21.3.202419:23EDGAR2Form 25-NSE - Notification filed by national security..
07.2.202423:19EDGAR2Form 8-K - Current report
06.2.202416:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202415:00EDGAR2Form 8-K - Current report
31.1.202423:17EDGAR2Form 8-K - Current report
23.1.202423:23EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23.1.202423:22EDGAR2Form 8-K - Current report
03.1.202423:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03.1.202423:02EDGAR2Form 8-K - Current report
03.1.202423:00EDGAR2Form 8-K - Current report
21.12.202318:31EDGAR2Form 8-K - Current report
21.12.202314:15GLOBEDMK Pharmaceuticals Regains Full Rights to Commercialize..
04.12.202322:47EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04.12.202322:45EDGAR2Form 8-K - Current report
28.11.202322:41EDGAR2Form 8-K - Current report
28.11.202314:05GLOBEDMK Pharmaceuticals Regains Full Rights from US WorldMeds..
15.11.202322:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15.11.202322:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15.11.202322:11EDGAR2Form 8-K - Current report
15.11.202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14.11.202321:57EDGAR2Form 8-K - Current report
14.11.202313:30GLOBEDMK Pharmaceuticals Reports Third Quarter 2023 Financial..
13.11.202316:52GLOBEDMK Pharmaceuticals Announces Presentation of Preclinical..
02.11.202321:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202321:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
30.10.202312:30GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
25.10.202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.10.202323:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
20.10.202322:15GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
19.10.202323:07EDGAR2Form 8-K - Current report
19.10.202322:05GLOBEDMK Pharmaceuticals Restructures Executive Team to Support..
17.10.202322:37EDGAR2Form 8-K - Current report
17.10.202318:28EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
12.10.202322:22EDGAR2Form DEFC14A - Definitive proxy statement, contested..
10.10.202312:01EDGAR2Form 8-K - Current report
02.10.202322:49EDGAR2Form PREC14A - Preliminary proxy statements, contested..
26.9.202314:37EDGAR2Form SC 13D/A - General statement of acquisition of..
19.9.202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202318:00GLOBEAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock